Matches in SemOpenAlex for { <https://semopenalex.org/work/W4229886947> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W4229886947 endingPage "S72" @default.
- W4229886947 startingPage "S72" @default.
- W4229886947 abstract "Centronuclear myopathies (CNM) are non-dystrophic muscle diseases for which no effective therapy is currently available. The most severe form, X-linked CNM, is caused by myotubularin 1 (MTM1) loss-of-function mutations, while the main autosomal dominant form is due to dynamin2 (DNM2) mutations. We previously showed that genetic reduction of DNM2 expression in Mtm1 knockout (Mtm1KO) mice prevents development of muscle pathology. Most recently we have shown that weekly systemic delivery of Dnm2 antisense oligonucleotides (ASOs) into Mtm1KO mice efficiently reduces DNM2 protein level in muscle and prevents the myopathy from developing. In addition, systemic weekly ASO injection into severely affected mice leads to reversal of muscle pathology within two weeks. Here we perform a single injection of ASO into 3-week-old Mtm1KO mice, and complete clinical, histological and molecular analysis of the duration of the effects after a single injection. A single injection of 25mg/kg of ASO targeting DNM2 increased the lifespan, whole body strength, and reduced disease severity in Mtm1KO mice compared to untreated controls. Despite these results, a single injection alone was not sufficient to rescue the disease for the lifespan of the mice, suggesting repeated treatments will be required. Thus, ASO-mediated DNM2 knockdown can efficiently correct muscle defects due to loss of MTM1, providing an attractive therapeutic strategy for this disease. We next analyzed myostatin levels in muscles and blood of Mtm1KO mice. We show myostatin levels in plasma are significantly reduced in Mtm1KO mice, and that treatment by ASOs targeting DNM2 significantly improves myostatin levels in plasma. In addition plasma myostatin levels inversely correlated with the level of DNM2 mRNA in muscles after injection with ASOs. This provides the first evidence of a blood based biomarker that can be used to monitor disease state and rescue in myotubular myopathy mice. With clinical trials for myotubular myopathy currently in progress, these results are of high relevance to the research field." @default.
- W4229886947 created "2022-05-11" @default.
- W4229886947 creator A5003123858 @default.
- W4229886947 creator A5013604896 @default.
- W4229886947 creator A5015729672 @default.
- W4229886947 creator A5015916772 @default.
- W4229886947 creator A5022449127 @default.
- W4229886947 creator A5023979875 @default.
- W4229886947 creator A5050024126 @default.
- W4229886947 creator A5051087623 @default.
- W4229886947 creator A5052813774 @default.
- W4229886947 creator A5060876331 @default.
- W4229886947 creator A5066396525 @default.
- W4229886947 date "2018-10-01" @default.
- W4229886947 modified "2023-09-25" @default.
- W4229886947 title "CONGENITAL MYOPATHIES (CNM)" @default.
- W4229886947 doi "https://doi.org/10.1016/j.nmd.2018.06.171" @default.
- W4229886947 hasPublicationYear "2018" @default.
- W4229886947 type Work @default.
- W4229886947 citedByCount "0" @default.
- W4229886947 crossrefType "journal-article" @default.
- W4229886947 hasAuthorship W4229886947A5003123858 @default.
- W4229886947 hasAuthorship W4229886947A5013604896 @default.
- W4229886947 hasAuthorship W4229886947A5015729672 @default.
- W4229886947 hasAuthorship W4229886947A5015916772 @default.
- W4229886947 hasAuthorship W4229886947A5022449127 @default.
- W4229886947 hasAuthorship W4229886947A5023979875 @default.
- W4229886947 hasAuthorship W4229886947A5050024126 @default.
- W4229886947 hasAuthorship W4229886947A5051087623 @default.
- W4229886947 hasAuthorship W4229886947A5052813774 @default.
- W4229886947 hasAuthorship W4229886947A5060876331 @default.
- W4229886947 hasAuthorship W4229886947A5066396525 @default.
- W4229886947 hasConcept C126322002 @default.
- W4229886947 hasConcept C134018914 @default.
- W4229886947 hasConcept C142724271 @default.
- W4229886947 hasConcept C170493617 @default.
- W4229886947 hasConcept C173396325 @default.
- W4229886947 hasConcept C182704531 @default.
- W4229886947 hasConcept C2777488582 @default.
- W4229886947 hasConcept C2779959927 @default.
- W4229886947 hasConcept C54355233 @default.
- W4229886947 hasConcept C71924100 @default.
- W4229886947 hasConcept C81885089 @default.
- W4229886947 hasConcept C86803240 @default.
- W4229886947 hasConceptScore W4229886947C126322002 @default.
- W4229886947 hasConceptScore W4229886947C134018914 @default.
- W4229886947 hasConceptScore W4229886947C142724271 @default.
- W4229886947 hasConceptScore W4229886947C170493617 @default.
- W4229886947 hasConceptScore W4229886947C173396325 @default.
- W4229886947 hasConceptScore W4229886947C182704531 @default.
- W4229886947 hasConceptScore W4229886947C2777488582 @default.
- W4229886947 hasConceptScore W4229886947C2779959927 @default.
- W4229886947 hasConceptScore W4229886947C54355233 @default.
- W4229886947 hasConceptScore W4229886947C71924100 @default.
- W4229886947 hasConceptScore W4229886947C81885089 @default.
- W4229886947 hasConceptScore W4229886947C86803240 @default.
- W4229886947 hasLocation W42298869471 @default.
- W4229886947 hasOpenAccess W4229886947 @default.
- W4229886947 hasPrimaryLocation W42298869471 @default.
- W4229886947 hasRelatedWork W1779480512 @default.
- W4229886947 hasRelatedWork W1977836459 @default.
- W4229886947 hasRelatedWork W1981654342 @default.
- W4229886947 hasRelatedWork W2003991696 @default.
- W4229886947 hasRelatedWork W2050592095 @default.
- W4229886947 hasRelatedWork W2058302049 @default.
- W4229886947 hasRelatedWork W2062221236 @default.
- W4229886947 hasRelatedWork W2309978229 @default.
- W4229886947 hasRelatedWork W2463478234 @default.
- W4229886947 hasRelatedWork W2893460394 @default.
- W4229886947 hasVolume "28" @default.
- W4229886947 isParatext "false" @default.
- W4229886947 isRetracted "false" @default.
- W4229886947 workType "article" @default.